James Walsh

Reporter | Medical Technology
Phone: 612-673-7428
James Walsh covers medical technology companies such as Medtronic and St. Jude and innovations.

Recent content from James Walsh

Minnesota serves as under-the-radar center for drug research

Despite state's prominence in drug testing, few who could benefit from early access to therapy know it exists.

Updated: June 15, 2012, - 09:19 PM

St. Jude settles U.S. suit, pays $3.65M

The federal government said the device maker didn't pay appropriate warranty credits.

Updated: May 31, 2012, - 09:17 PM

Eden Prairie firm wins approval to sell prostate imaging technology

ProUroCare says its device can help doctors detect possible prostate problems and map changes to the prostate over time.

Updated: May 26, 2012, - 05:10 PM

International growth helps Medtronic beat estimates

Med-tech firm will reduce the U.S. workforce by 1,000 but add 1,500 abroad in fiscal year 2013.

Updated: May 22, 2012, - 09:11 PM

A less-invasive way to replace heart valves

Analysts see a booming market for transcatheter heart valves. But most of the sales will be in Europe -- for now.

Updated: May 20, 2012, - 08:41 AM

Lifesaving products are Roseville firm's lifeblood

Advanced Circulatory Systems' devices have found a niche with the military and paramedics.

Updated: May 19, 2012, - 06:46 AM

Medtronic: Feds close Infuse probe

Prosecutors studied whether it had promoted "off-label" uses for its bone graft product but found no wrongdoing, the company said.

Updated: May 16, 2012, - 09:20 PM

Get in touch with nature in Sioux Falls

On a recent trip to Sioux Falls, S.D., we discovered something we had never noticed before. The falls. It was a green oasis on a gorgeous early March day.

Updated: May 12, 2012, - 01:15 PM

St. Jude's Riata leads fared worse in new study

A Minneapolis cardiologist reported the defibrillator wires had a nearly 2 percent a year failure rate, higher than expected.

Updated: May 11, 2012, - 09:13 PM

St. Jude's new generation of defibrillators

The company says its latest FDA-approved defibrillators are better at treating heart problems and less likely to give unneeded jolts.

Updated: May 08, 2012, - 10:07 PM

Result Per Page
  • 58°
  • 62/48
  • Cloudy

The Drive: Metro traffic

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters
Search by category

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT